We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Proposed changes to the way the FDA considers risks and benefits of 510(k) devices could undermine the efficiency and predictability of the popular market clearance route, a lead industry attorney says. Read More